Thomas Kacius

Thomas Kacius is currently working as a Manager at Basis. Prior to this role, Thomas held positions as a Consultant and Senior Analyst at ClearView Healthcare Partners. In addition, Thomas has experience as an Undergraduate Research Assistant at the University of Notre Dame - College of Science, where Thomas researched the biosynthesis of anti-fungal agent Ambruticin F. Thomas has also interned at Eli Lilly and Company as a Medicines Innovation Hub Intern. Thomas holds a degree in Biochemistry with a minor in Bioengineering from the University of Notre Dame, where Thomas was also a Valedictorian at Cathedral High School.